RHO and tauopathy: Our study suggested that Rho-ROCK inhibitors markedly reduce oligomeric tau and activate autophagy based on a cell culture model of tauopathy (M1C cells) and mouse model of tauopathy (rTg4510), although the autophagy-activating pathway remains unclear [48] (Table 1).